Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,516.70
(
-1.14%
)
US TECH 100
23,153.20
(
-1.53%
)
Dow Jones
46,080.96
(
-0.75%
)
Brent Oil
102.53
(
3.80%
)
Bitcoin
68,928.56
(
-3.33%
)
News Focus
News Focus
Post# of 257293
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122813
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 207091

Tuesday, 01/24/2017 10:14:20 AM

Tuesday, January 24, 2017 10:14:20 AM

Post# of 257293
ABBV/ENTA—EMA grants accelerated assessment for G/P HCV regimen:

http://finance.yahoo.com/news/enanta-announces-ema-grants-accelerated-090500651.html

EMA accelerated assessment is similar to FDA’s BTD and priority review. As a result of the AA designation, the CHMP could approve G/P as early as 2H17.

Please chase the links in #msg-127281791 for related info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today